BPA Call 75F40122A00013-75F40123F19005
- This is a contract award to Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering services, by the Food and Drug Administration (FDA). The contract, valued at $7,647,580.46, is a Blanket Purchase Agreement (BPA) call under a larger Regulatory Review Support Services BPA. The work to be performed includes AIRRS/CIRDS support, which likely refers to regulatory review and information systems support for the FDA. The contract is not set aside and has a period of...
- This is a federal contract award from the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a prominent management, technology, and engineering services firm. The contract is for "Regulatory Science Optimization and Support" services, with a ceiling value of $3,802,146.30 and a performance period ending on September 21, 2028. The contract type is a Blanket Purchase Agreement (BPA) call, with a pricing structure of labor hours. The contract is not set aside for any...
- Booz Allen Hamilton Inc. received a task order award under the Office of Management and Budget's Federal Procurement Data System (OMUFA) Blanket Purchase Agreement (BPA) from the Food and Drug Administration (FDA) on April 24, 2026. This labor-hour contract has a ceiling value of approximately $2.9 million and is scheduled for completion by April 23, 2027. The work will be performed in Silver Spring, Maryland, where the FDA maintains significant operations. The award is not designated with a...
- This federal contract award, valued at $1,999,469.75, was issued by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a prominent management and technology consulting firm, to provide Health Fraud Surveillance AI/ML Tool Services. The contract is a Blanket Purchase Agreement (BPA) Call under the Multiple Award Schedule (MAS) contract vehicle. The contract does not have a set-aside designation, indicating it was a full and open competition award. Booz Allen Hamilton Inc. is a...
- Booz Allen Hamilton Inc., a McLean, Virginia-based management and technology services firm, received a no-cost extension modification to its NextGen RBIS (Regulatory Business Information System) Development, Modernization and Enhancement contract with the Food and Drug Administration. The contract, awarded March 23, 2023, carries a ceiling value of $10.5 million and operates under a Blanket Purchase Agreement (BPA) call against the General Services Administration's Multiple Award Schedule....
- This federal contract award is for Regulatory Business Information Services (RBIS) Operations and Maintenance (O&M) and Development, Modernization and Enhancement (DME) Support Services, awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc. as the prime contractor. The contract has a ceiling value of $7,713,785.26 and a period of performance ending on September 25, 2017. The contract is issued as a Blanket Purchase Agreement (BPA) call under the General Services...
- The U.S. Food and Drug Administration awarded a task order to Booz Allen Hamilton Inc. on March 25, 2026, under a Blanket Purchase Agreement to provide Operations & Maintenance and Durable Medical Equipment support services related to the OII RBIS system. This task order, valued at approximately $11.3 million with an ultimate completion date of July 31, 2027, represents labor-hour pricing and will be performed in Brinklow, Maryland. The award is issued under the General Services...
- This federal contract award from the Food and Drug Administration (FDA) is for the CDER Informatics Enterprise Service and Operation Modernization project. It is a $17,461,833.28 Blanket Purchase Agreement (BPA) call awarded to Booz Allen Hamilton Inc. under the Multiple Award Schedule (MAS) contract. The contract will provide informatics enterprise services and operations modernization support to the FDA's Center for Drug Evaluation and Research (CDER) over a 3-year period until January 2025....
- Booz Allen Hamilton Inc. has been awarded a modification to its NextGen Reduced Business Information System (RBIS) Operations and Maintenance contract with the Food and Drug Administration, with a ceiling value of $3.74 million and an ultimate completion date of July 31, 2027. This contract, awarded as a Blanket Purchase Agreement call under the General Services Administration's Multiple Award Schedule, represents a firm fixed-price engagement for operations and maintenance services supporting...
- The Food and Drug Administration (FDA) awarded a $375,403.52 labor hour type Blanket Purchase Agreement (BPA) call order contract to Booz Allen Hamilton Inc. (BAH) to provide Regulatory Business Information Services (RBIS) Health Fraud System Service Support. BAH, a subsidiary of Booz Allen Hamilton Holding Corporation, will draw from its Multiple Award Schedule contract vehicle to perform the work in Rockville, Maryland from March 2022 through March 2023. The contract is for labor hours to...
- Multiple Award Schedule (MAS)Master GSA Schedule
- GS35F386DA-75F40122A00013Blanket Purchase Agreement
- 75F40122A00013-75F40123F19005BPA Call
Booz Allen Hamilton Inc. received a contract award from the Food and Drug Administration (FDA) for the NextGen RBIS ORA Health Fraud Surveillance Platform Development, Modernization and Enhancement (DME) and Operations and Maintenance (O&M). This contract, issued as a Blanket Purchase Agreement (BPA) call under the General Services Administration's Multiple Award Schedule (MAS), carries a ceiling value of $669,034.16 and operates on a labor-hours pricing model. The award is a modification to update accounting information for the existing platform development and maintenance effort. The contract was awarded on March 24, 2023, with an ultimate completion date of March 24, 2024, and will be performed in Calverton, Maryland. The NextGen RBIS ORA platform supports the FDA's Office of Regulatory Affairs' critical health fraud surveillance capabilities, combining development, modernization, and enhancement activities with ongoing operations and maintenance services. Booz Allen Hamilton, a McLean, Virginia-based management, technology, and engineering services firm with extensive experience supporting federal civilian agencies, is well-positioned to deliver these services given its substantial portfolio of FDA task orders spanning electronic submissions, regulatory science optimization, and biomarker tracking support. This award does not carry a small business set-aside designation, reflecting Booz Allen Hamilton's status as a large business prime contractor competing in full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Close Out | ($1k) | 9/3/24 | |
| P00001 | Other Administrative Action | $0 | 4/4/23 | |
| Not listed | Not listed | $670.3k | 3/24/23 |